Acurx Pharmaceuticals, Inc.
ACXP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,707 | $7,474 | $9,112 | $12,959 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $51 | $129 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $100 | $106 | $265 | $295 |
| Total Curr. Assets | $3,858 | $7,709 | $9,377 | $13,254 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,858 | $7,709 | $9,377 | $13,254 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3,243 | $3,042 | $2,062 | $844 |
| Total Curr. Liab. | $3,243 | $3,042 | $2,062 | $844 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,243 | $3,042 | $2,062 | $844 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $17 | $14 | $12 | $10 |
| Retained Earnings | -$67,322 | -$53,219 | -$38,641 | -$26,548 |
| AOCI | $0 | $0 | -$38,641 | -$26,548 |
| Other Equity | $67,920 | $57,871 | $84,586 | $65,497 |
| Total Equity | $615 | $4,667 | $7,315 | $12,410 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,858 | $7,709 | $9,377 | $13,254 |
| Net Debt | -$3,707 | -$7,474 | -$9,112 | -$12,959 |